ONCOLOGY & HEMATOLOGY JOURNALS
European Oncology & Haematology and Oncology & Hematology Review (US) are peer-reviewed, free-to-access, bi-annual journals specializing in the publication of balanced and comprehensive review articles written by leading authorities to address the most important and salient developments in the fields of oncology and hematology. The aim of these reviews is to break down the high science from ‘data-rich’ primary papers and provide practical advice and opinion on how this information can help physicians in the day to day clinical setting. Special reports, editorials, case reports, and original research articles are also featured to promote discussion and learning amongst physicians, clinicians, researchers and related healthcare professionals.
The journal is of interest to physicians, health care professionals and researchers across Europe and the US, providing practical advice relevant to the clinical setting on the diagnosis and treatment of oncologic and hematologic conditions. European Oncology & Haematology and Oncology & Hematology Review (US) endeavour to support these professionals in continuously developing their knowledge, effectiveness and productivity.
Articles are independently commissioned by the journals Managing Editor following specialist advice from the Editorial Board, which features the most senior experts within Oncology & Hematology. The Editor is always keen to hear from leading authorities wishing to discuss potential submissions. Please complete the our submissions form and the Editor will be in touch regarding your proposal.
Touch Medical Media endeavours to publish unbiased, balanced reviews and studies and follow the publication guidelines as recommended by the ICMJE (www.icmje.org) and in the Good Publication Practice guidelines (www.ismpp.org/gpp3). All authors are asked to disclose personal, commercial, academic, and financial interests in the Disclosures section, along with any funding, financial support and medical writing assistance relating to the paper. All articles undergo a rigorous, double-blind peer review, conducted by at least two independent experts in the field to ensure articles are balanced, objective and relevant to the current clinical landscape. Please download our Instructions for Authors information for further details.
INFORMATION FOR AUTHORS
The editor is always keen to receive pre-submission enquiries from prospective authors. Please contact the Editor with the article title and abstract for feedback.
Authors should carefully read and adhere to the journal’s Instructions for Authors. The documents below provide information for authors to complete the submission process:
touchONCOLOGY aims to publish unbiased, balanced reviews and studies. Authors should adhere to the journal’s publication ethics and malpractice statement, which can be found below.
Link to the latest good publication guidelines can be found below:
The journals welcome authors to submit accompanying multimedia content. Please contact the Editor for more information.
Statement to authors and reviewers regarding COVID-19
We appreciate that, in this unprecedented and difficult time of world pandemic, many of you will be leading the response to COVID-19 and therefore any timelines you may have agreed to as a submitting author and/or peer reviewer are likely to be affected. Please contact the team if you have any issues or concerns – we are committed to being flexible and are happy to help however we can.
Manuscripts can be submitted through the touchONCOLOGY Editorial Manager site. If you are a new user please follow the instructions to register.
On submission, all articles are assessed by the Editor, and where necessary a member of the Editorial Board, to determine their suitability for inclusion and appropriateness for peer review. Articles undergo a strict, double-blind peer review, conducted by at least two independent experts in the field. Touch Medical Media has a strict policy against plagiarism. We use anti-plagiarism software including iThenticate to check all submissions before peer review.
Authors will be notified of the peer review decision through Editorial Manager within 3-4 weeks of submission.
The article proofs are prepared within 2 weeks of acceptance. The article is copyedited to house style and checked for grammatical error, then typeset to produce the page proofs. The editorial team will contact the author directly with the page proofs, which may include some minor editorial queries to address. The authors are asked to review and clearly annotate the page proofs with any corrections. Annotated page proofs should be returned to the editor, who will issue the final corrected proofs for approval.
Articles are published online ahead of print before the journal issue goes to print.
Access and Sharing
All articles are free-to-access for all members of the oncology and hematology community. Authors are encouraged to share their published article with colleagues and peers through social media.
INFORMATION FOR PEER REVIEWERS
All manuscripts submitted to Touch Medical Media journals, with the exception of editorials and special reports, undergo double-blind peer review. The process aims to provide authors with objective feedback to improve their work and allows the editor to assess the paper’s suitability for publication in the journal.
Peer reviewers should carefully read and adhere to the instructions outlined in the document below. Please refer to these instructions before accepting to review a paper and throughout the review process.